MCMCB Pro
M1422

M1422Gastroenterology care mips value pathway

HCPCSActiveBETOS Z2

M1422 is a HCPCS Level II code for gastroenterology care mips value pathway. It belongs to the Medical Services section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusM

Measurement code. Used for reporting purposes only; never paid.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for M1422

Long descriptor
Gastroenterology care mips value pathway

The official wording. This is what the code means.

Short descriptor
Gastroenterology care mvp

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2025

When CMS introduced the code.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to M1422

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1422 is not quite right, the correct code is very often within a few positions of it.

  • M1414Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)
  • M1415Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
  • M1416Patient received hospice services any time during the performance period
  • M1417Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
  • M1418Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician
  • M1419Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
  • M1420Complete ophthalmologic care mips value pathway
  • M1421Dermatological care mips value pathway
  • M1423Optimal care for patients with urologic conditions mips value pathway
  • M1424Pulmonology care mips value pathway
  • M1425Surgical care mips value pathway
  • M1426Encounters conducted via telehealth
  • M1427Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons)
  • M1428Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period
  • M1429Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented
  • M1430Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year)

Questions about M1422

What is HCPCS code M1422?

M1422 is a HCPCS Level II code for gastroenterology care mips value pathway. It sits in the Medical Services section.

Does Medicare cover M1422?

The CMS HCPCS file marks M1422 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is M1422 paid under the physician fee schedule?

M1422 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.

HCPCS Level II2026Q3-Jul· effective July 1, 2026